
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
Bruce Kirkham, Arthur Kavanaugh, Kristian Reich
Immunology (2013) Vol. 141, Iss. 2, pp. 133-142
Open Access | Times Cited: 226
Bruce Kirkham, Arthur Kavanaugh, Kristian Reich
Immunology (2013) Vol. 141, Iss. 2, pp. 133-142
Open Access | Times Cited: 226
Showing 1-25 of 226 citing articles:
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Iain B. McInnes, Philip J. Mease, Bruce Kirkham, et al.
The Lancet (2015) Vol. 386, Iss. 9999, pp. 1137-1146
Open Access | Times Cited: 785
Iain B. McInnes, Philip J. Mease, Bruce Kirkham, et al.
The Lancet (2015) Vol. 386, Iss. 9999, pp. 1137-1146
Open Access | Times Cited: 785
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Andrew Blauvelt, Andrea Chiricozzi
Clinical Reviews in Allergy & Immunology (2018) Vol. 55, Iss. 3, pp. 379-390
Open Access | Times Cited: 583
Andrew Blauvelt, Andrea Chiricozzi
Clinical Reviews in Allergy & Immunology (2018) Vol. 55, Iss. 3, pp. 379-390
Open Access | Times Cited: 583
The pathogenesis of psoriatic arthritis
Douglas J. Veale, Ursula Fearon
The Lancet (2018) Vol. 391, Iss. 10136, pp. 2273-2284
Closed Access | Times Cited: 442
Douglas J. Veale, Ursula Fearon
The Lancet (2018) Vol. 391, Iss. 10136, pp. 2273-2284
Closed Access | Times Cited: 442
The IL-23–IL-17 axis in inflammatory arthritis
Erik Lubberts
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 7, pp. 415-429
Closed Access | Times Cited: 393
Erik Lubberts
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 7, pp. 415-429
Closed Access | Times Cited: 393
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Nicolò Costantino Brembilla, Luisa Senra, Wolf‐Henning Boehncke
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 377
Nicolò Costantino Brembilla, Luisa Senra, Wolf‐Henning Boehncke
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 377
Interleukin-17 and innate immunity in infections and chronic inflammation
Natasa Isailovic, Kenji Daigo, Alberto Mantovani, et al.
Journal of Autoimmunity (2015) Vol. 60, pp. 1-11
Closed Access | Times Cited: 346
Natasa Isailovic, Kenji Daigo, Alberto Mantovani, et al.
Journal of Autoimmunity (2015) Vol. 60, pp. 1-11
Closed Access | Times Cited: 346
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
José María García Ruiz de Morales, L. Puig, E. Daudén, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 1, pp. 102429-102429
Open Access | Times Cited: 271
José María García Ruiz de Morales, L. Puig, E. Daudén, et al.
Autoimmunity Reviews (2019) Vol. 19, Iss. 1, pp. 102429-102429
Open Access | Times Cited: 271
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249
Old and New Biological Therapies for Psoriasis
Kirsten Rønholt, Lars Iversen
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2297-2297
Open Access | Times Cited: 217
Kirsten Rønholt, Lars Iversen
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2297-2297
Open Access | Times Cited: 217
Modulation of Protein–Protein Interactions for the Development of Novel Therapeutics
Ιωάννα Πέττα, Sam Lievens, Claude Libert, et al.
Molecular Therapy (2015) Vol. 24, Iss. 4, pp. 707-718
Open Access | Times Cited: 200
Ιωάννα Πέττα, Sam Lievens, Claude Libert, et al.
Molecular Therapy (2015) Vol. 24, Iss. 4, pp. 707-718
Open Access | Times Cited: 200
Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration
Anthony L. Mescher
Regeneration (2017) Vol. 4, Iss. 2, pp. 39-53
Open Access | Times Cited: 186
Anthony L. Mescher
Regeneration (2017) Vol. 4, Iss. 2, pp. 39-53
Open Access | Times Cited: 186
Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL ‐17A inhibition in psoriasis
Kristian Reich, Kim Papp, Robert Matheson, et al.
Experimental Dermatology (2015) Vol. 24, Iss. 7, pp. 529-535
Open Access | Times Cited: 181
Kristian Reich, Kim Papp, Robert Matheson, et al.
Experimental Dermatology (2015) Vol. 24, Iss. 7, pp. 529-535
Open Access | Times Cited: 181
Current Developments in the Immunology of Psoriasis.
Franziska Grän, Andreas Kerstan, Edgar Serfling, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 1, pp. 97-110
Closed Access | Times Cited: 171
Franziska Grän, Andreas Kerstan, Edgar Serfling, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 1, pp. 97-110
Closed Access | Times Cited: 171
The psychosocial burden of psoriatic arthritis
M. Elaine Husni, Joseph F. Merola, Sara Davin
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 3, pp. 351-360
Open Access | Times Cited: 151
M. Elaine Husni, Joseph F. Merola, Sara Davin
Seminars in Arthritis and Rheumatism (2017) Vol. 47, Iss. 3, pp. 351-360
Open Access | Times Cited: 151
New mechanism underlying IL-31–induced atopic dermatitis
Jianghui Meng, Masaki Moriyama, M Feld, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 141, Iss. 5, pp. 1677-1689.e8
Open Access | Times Cited: 149
Jianghui Meng, Masaki Moriyama, M Feld, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 141, Iss. 5, pp. 1677-1689.e8
Open Access | Times Cited: 149
Th17‐ and Treg‐related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease
Mindy Ming‐Huey Guo, Wei‐Che Tseng, Cheng‐Hao Ko, et al.
Allergy (2014) Vol. 70, Iss. 3, pp. 310-318
Closed Access | Times Cited: 139
Mindy Ming‐Huey Guo, Wei‐Che Tseng, Cheng‐Hao Ko, et al.
Allergy (2014) Vol. 70, Iss. 3, pp. 310-318
Closed Access | Times Cited: 139
Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors
Wei Gao, Trudy McGarry, C. Orr, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 1, pp. 311-315
Open Access | Times Cited: 132
Wei Gao, Trudy McGarry, C. Orr, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 1, pp. 311-315
Open Access | Times Cited: 132
Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito
Cells (2019) Vol. 8, Iss. 8, pp. 818-818
Open Access | Times Cited: 131
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito
Cells (2019) Vol. 8, Iss. 8, pp. 818-818
Open Access | Times Cited: 131
Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type
Joseph Fabre, Jérôme Giustiniani, Christian Garbar, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1433-1433
Open Access | Times Cited: 130
Joseph Fabre, Jérôme Giustiniani, Christian Garbar, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1433-1433
Open Access | Times Cited: 130
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
Josef S Smolen, Sandeep K. Agarwal, Е. П. Иливанова, et al.
Annals of the Rheumatic Diseases (2017) Vol. 76, Iss. 5, pp. 831-839
Open Access | Times Cited: 129
Josef S Smolen, Sandeep K. Agarwal, Е. П. Иливанова, et al.
Annals of the Rheumatic Diseases (2017) Vol. 76, Iss. 5, pp. 831-839
Open Access | Times Cited: 129
Cellular sources of IL ‐17 in psoriasis: a paradigm shift?
R.R.M.C. Keijsers, Irma Joosten, P.E.J. van Erp, et al.
Experimental Dermatology (2014) Vol. 23, Iss. 11, pp. 799-803
Open Access | Times Cited: 119
R.R.M.C. Keijsers, Irma Joosten, P.E.J. van Erp, et al.
Experimental Dermatology (2014) Vol. 23, Iss. 11, pp. 799-803
Open Access | Times Cited: 119
Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice
Shuangshuang Zhang, Xiangdong Liu, Lihong Mei, et al.
BMC Complementary and Alternative Medicine (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 103
Shuangshuang Zhang, Xiangdong Liu, Lihong Mei, et al.
BMC Complementary and Alternative Medicine (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 103
Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis
Benjamin Lockshin, Yevgeniy Balagula, Joseph F. Merola
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 2, pp. 345-352
Open Access | Times Cited: 100
Benjamin Lockshin, Yevgeniy Balagula, Joseph F. Merola
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 2, pp. 345-352
Open Access | Times Cited: 100
γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection
Carolina Maiumi Shiromizu, Carolina Jancic
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 95
Carolina Maiumi Shiromizu, Carolina Jancic
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 95
CD8+ T cells in human autoimmune arthritis: the unusual suspects
Alessandra Petrelli, Femke van Wijk
Nature Reviews Rheumatology (2016) Vol. 12, Iss. 7, pp. 421-428
Closed Access | Times Cited: 88
Alessandra Petrelli, Femke van Wijk
Nature Reviews Rheumatology (2016) Vol. 12, Iss. 7, pp. 421-428
Closed Access | Times Cited: 88